Trials / Withdrawn
WithdrawnNCT05036122
Estimating Blood [Lactate] Non-Invasively
Validation of a Non-Invasive Instrument to Estimate Blood Lactate
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to validate the LabClasp's ability to estimate blood \[lactate\].
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LabClasp | Non-invasive device that estimates blood \[lactate\] from interstitial fluid via a proprietary algorithm. The device is placed between the first and second knuckle of a finger and gently applies slight pressure to extract interstitial fluid from the skin. Sensors within the device quickly estimate blood \[lactate\] and return a value to the subject via an accompanying tablet within 20 seconds. |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2026-09-01
- Completion
- 2026-12-01
- First posted
- 2021-09-05
- Last updated
- 2026-03-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05036122. Inclusion in this directory is not an endorsement.